COVID-19
TOOLBOX
Filter
26
Featured
Language
Document type
Resource Platforms
10
Studies & Reports
5
Fact sheets
4
Guidelines
2
Manuals
1
Training Material
1
Situation Updates
1
Infographics
1
Videos
1
Countries / Regions
West and Central Africa
3
East and Southern Africa
3
Africa
2
Germany
2
Middle East and North Africa
2
Mozambique
1
Guinea-Bissau
1
Latin America and the Carribbean
1
Western and Central Europe
1
Brazil
1
Russia
1
Angola
1
Authors & Publishers
World Health Organization WHO
10
Africa CDC Centres for Disease Control and Prevention
4
African Union
4
Paul Ehrlich Institute
2
Clinical Care Options
1
European Medicines Agency EMA
1
Kamradt, T., and B.S. Kamps
1
Kamradt, T., B.S. Kamps J. García-Rosales Delgado
1
Kim, A.
1
New England Journal of Medicine
1
New York Times
1
OPAS, OMS
1
Organisation Mondiale de la Santé OMS
1
Pan American Health Organisation PAHO
1
S.R. Lewin and R. Sherer
1
TASS russian news agency
1
Vaccine Centre at the London School of Hygiene & Tropical Medicine
1
World Health Organization WHO, et al.
1
Zimmer, C, J. Corum and S. Wee
1
Publication Years
Category
COVID-19
10
Studies & Reports
1
Immunization
1
Toolboxes
Research & Pipeline
26
Scientific & Research Studies
7
mRna Vaccines general
6
Vector-based Vacines General
6
Vaccine Candidates & Research
5
Dashboards & Resource Platforms
5
Prevention & Preparedness
1
Training, others
1
Essential Medicines & Medical Devices
1
Access & Strategy
1
Communication Material
1
Immunization Guidelines
1
Logistics & Supply
1
SARS-CoV-2 Variants
1
Inactivated COVID-19 Vaccines
1
Pharmacovigilance
1
This tracker, developed by the Vaccine Centre at the London School of Hygiene & Tropical Medicine, will follow COVID-19 vaccine candidates as they progress through the development pipeline. We will update it weekly. An overview of the different vaccine types as well as the phases of clinical develo... more
La stratégie continentale commune africaine pour COVID-19 est sous-tendue par la nécessité de limiter la transmission, de prévenir les décès et de réduire les dommages associés. La participation des nations africaines aux essais cliniques est une étape essentielle pour garantir la productio... more
The conduct of COVID-19 vaccine trials in the context of a candidate vaccine being issued with Emergency Use Designation raises challenging ethical questions, including in relation to the use of placebo controls and unblinding of trial participants in current and future COVID-19 vaccine trials. This... more
August 2020, The Africa Joint Continental Strategy for COVID-19 is underpinned by the need to limit transmission, prevent deaths and reduce associated harms. Participation by African nations in clinical trials is an essential step to ensure that sufficient data is generated on the safety and efficac... more
Evaluation of the effectiveness of vaccines against COVID-19 INTERIM GUIDANCE 17 MARCH 2021